These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 27566041)
1. From bench to bedside: Clinical implications of KRAS status in patients with colorectal liver metastasis. Andreatos N; Ronnekleiv-Kelly S; Margonis GA; Sasaki K; Gani F; Amini N; Wilson A; Pawlik TM Surg Oncol; 2016 Sep; 25(3):332-8. PubMed ID: 27566041 [TBL] [Abstract][Full Text] [Related]
2. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence. Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183 [TBL] [Abstract][Full Text] [Related]
4. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer. Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910 [TBL] [Abstract][Full Text] [Related]
5. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases. Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912 [TBL] [Abstract][Full Text] [Related]
6. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis. Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887 [TBL] [Abstract][Full Text] [Related]
7. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis. Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246 [TBL] [Abstract][Full Text] [Related]
8. Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis. Passiglia F; Bronte G; Bazan V; Galvano A; Vincenzi B; Russo A Crit Rev Oncol Hematol; 2016 Mar; 99():150-7. PubMed ID: 26775732 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Role of BRAF Mutations in Colorectal Cancer Liver Metastases. Pikoulis E; Margonis GA; Andreatos N; Sasaki K; Angelou A; Polychronidis G; Pikouli A; Riza E; Pawlik TM; Antoniou E Anticancer Res; 2016 Sep; 36(9):4805-11. PubMed ID: 27630332 [TBL] [Abstract][Full Text] [Related]
17. The interplay of KRAS mutational status with tumor laterality in non-metastatic colorectal cancer: An international, multi-institutional study in patients with known KRAS, BRAF, and MSI status. Kamphues C; Kadowaki S; Amini N; van den Berg I; Wang J; Andreatos N; Sakamoto Y; Ogura T; Kakuta M; Pikouli A; Geka D; Daitoku N; Theochari M; Buettner S; Akiyama T; Antoniou E; Pikoulis E; Theodoropoulos G; Imai K; Ijzermans JNM; Margonis GA; Akagi K; Kreis ME J Surg Oncol; 2021 Mar; 123(4):1005-1014. PubMed ID: 33368279 [TBL] [Abstract][Full Text] [Related]
18. Not All Kirsten Rat Sarcoma Viral Oncogene Homolog Mutations Predict Poor Survival in Patients With Unresectable Colorectal Liver Metastasis. Lin Z; Liu Y; Cai S; Yang C; Zhou L; Li W Technol Cancer Res Treat; 2021; 20():15330338211039131. PubMed ID: 34669528 [No Abstract] [Full Text] [Related]
19. Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases. Sakai N; Furukawa K; Takayashiki T; Kuboki S; Takano S; Ohtsuka M BMC Cancer; 2021 Apr; 21(1):412. PubMed ID: 33858364 [TBL] [Abstract][Full Text] [Related]
20. Impact of BRAF mutations on clinical outcomes following liver surgery for colorectal liver metastases: An updated meta-analysis. Gau L; Ribeiro M; Pereira B; Poirot K; Dupré A; Pezet D; Gagnière J Eur J Surg Oncol; 2021 Nov; 47(11):2722-2733. PubMed ID: 34099355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]